Why Blood Work Is Non-Negotiable
Blood work serves two critical functions in peptide therapy: safety (catching problems before they become serious) and optimization (confirming the protocol is actually doing what you want). Without labs, you're flying blind — you don't know if your IGF-1 is in the optimal range, your liver enzymes are stable, or your metabolic markers are actually improving.
The Universal Baseline Panel
Every person starting peptide therapy should have these panels drawn before their first dose:
| Panel | What It Measures | Why You Need It |
|---|---|---|
| Comprehensive Metabolic Panel (CMP) | Liver enzymes (AST, ALT), kidney function (BUN, creatinine), electrolytes, glucose | Baseline organ function. Any peptide could theoretically affect liver/kidney metabolism. You need a "before" snapshot. |
| Complete Blood Count (CBC) | Red/white blood cells, hemoglobin, hematocrit, platelets | Overall health baseline. Detects anemia, infection, or blood cell abnormalities that could contraindicate certain peptides. |
| Lipid Panel | Total cholesterol, LDL, HDL, triglycerides | Cardiovascular baseline. GLP-1s and GH peptides can affect lipid profiles — you want to track the change. |
| Fasting Glucose + HbA1c | Current blood sugar + 3-month average | Metabolic baseline. Essential for GLP-1s, MOTS-C, and any metabolic peptide. |
| CRP (C-Reactive Protein) | Systemic inflammation | Inflammation baseline. BPC-157, KPV, and immune peptides should improve this marker over time. |
Additional Panels by Peptide Type
| If Using | Add These Panels | Why |
|---|---|---|
| GH peptides (CJC-1295, Ipamorelin, Tesamorelin) | IGF-1, Insulin, Fasting Glucose | Monitor GH output (IGF-1 should stay upper-normal, not excessively elevated). GH affects insulin sensitivity. |
| GLP-1s (Semaglutide, Tirzepatide) | HbA1c, Lipase, Amylase, Thyroid panel | Monitor blood sugar improvement, screen for pancreatitis risk, thyroid monitoring (rodent thyroid concerns). |
| Immune peptides (Thymosin Alpha-1, Selank) | CBC with differential, IgG/IgA/IgM | Track immune cell populations and immunoglobulin levels. |
| Hormonal peptides (Kisspeptin, PT-141) | LH, FSH, Testosterone (total+free), Estradiol, SHBG | Hormonal baseline and monitoring for endocrine effects. |
| Longevity stack (Epitalon, NAD+, GHK-Cu) | IGF-1, Vitamin D, DHEA-S, Homocysteine | Comprehensive aging biomarkers. Optional: telomere length assay at baseline and 6-12 months. |
| Metabolic peptides (MOTS-C, AOD-9604) | Fasting Insulin, HbA1c, Thyroid panel | Track insulin sensitivity improvement and metabolic rate changes. |
When to Test
| Timing | Purpose | Panels |
|---|---|---|
| Baseline (before starting) | Establish your "before" snapshot | Full universal panel + peptide-specific additions |
| Week 8-12 | First progress check | Repeat universal panel + peptide-specific. Compare to baseline. |
| Quarterly (ongoing) | Ongoing safety monitoring | CMP, CBC, plus IGF-1 if on GH peptides, HbA1c if on GLP-1s |
| End of cycle | Assess cycle impact before break | Full panel — evaluate what changed |
| Annually | Comprehensive review | Everything — full universal + all applicable specialized panels |
Reading Your Results: Key Markers
IGF-1 (Growth Hormone Peptides)
Target: upper third of the age-adjusted reference range. If your lab's range is 100-300 ng/mL, you want to be 200-300, not 400+. Excessively elevated IGF-1 (consistently above range) is associated with increased cancer risk in epidemiological studies. If above range, reduce GH peptide dose.
HbA1c (GLP-1s & Metabolic Peptides)
Target: improvement toward 5.0-5.6% (optimal). If starting above 6.5% (diabetic range), expect gradual improvement over 12-24 weeks on GLP-1 therapy. A drop of 0.5-1.5% is typical with semaglutide.
CRP (Inflammatory Marker)
Target: below 1.0 mg/L (low cardiovascular risk). BPC-157, KPV, and immune peptides should trend this downward. If rising, evaluate for new inflammation sources or protocol adjustments.
Liver Enzymes (AST/ALT)
Monitor for stability. Mild elevations (1-2x upper limit) can occur with some compounds and may be transient. Persistent or significant elevations (>3x) warrant protocol review and provider consultation.
Where to Get Labs Affordably
- Direct-to-consumer lab companies: Order labs yourself without a doctor's order. Results in 1-3 business days. Examples: Walk-In Lab, Ulta Lab Tests, Jason Health.
- Your provider: If you have a peptide-friendly provider, they'll order labs directly. May be covered by insurance as "wellness" or "preventive" if coded appropriately.
- Telehealth peptide providers: Most include initial and follow-up lab orders as part of their consultation fee.
- Discount tip: The universal baseline panel (CMP, CBC, lipids, HbA1c, CRP) typically costs $50-100 through direct-to-consumer labs — significantly less than hospital or clinic pricing.
Frequently Asked Questions
Related Articles
Not Sure Which Peptide Is Right for You?
Take our free 60-second quiz and get personalized recommendations based on your goals.
Take the Quiz →